Cantor Fitzgerald Reiterates Overweight on Vaxcyte
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Vaxcyte (NASDAQ:PCVX).
June 20, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Vaxcyte, indicating a positive outlook for the stock.
An Overweight rating from a reputable analyst like Louise Chen suggests a positive outlook for Vaxcyte, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100